Literature DB >> 29669437

Development of hydrogels, oleogels, and bigels as local drug delivery systems for periodontitis.

Rania Hamed1, Ala'a AbuRezeq1, Ola Tarawneh1.   

Abstract

Periodontal disease is a chronic inflammation of gum and tissues that surround and support the teeth. Nonsteroidal anti-inflammatory drugs (NSAIDs) can be used in the treatment of periodontitis to ease swelling and inflammation. One approach of treating periodontitis is loading the NSAIDs in local drug delivery systems. Therefore, the objective of this study was to investigate the local delivery of the NSAIDs model drug ibuprofen to treat periodontitis using different types of gel formulations (hydrogel, oleogel, and bigel). Gel formulations were characterized in terms of their rheological properties (flow behavior, viscoelastic, and bioadhesive properties) using a controlled-stress rheometer. The in vitro drug release of ibuprofen from gel formulations was investigated using Franz diffusion cells. Gels exhibited more solid-like (elastic) behavior. The viscosity and viscoelastic properties were in the order of oleogel > bigel > hydrogel, respectively. In bioadhesion study, mucin dispersion/plain ibuprofen-hydrogel mixture showed a frequency-dependent interaction of ΔG' = -31 and ΔG' = + 53 Pa at 1 and 10 rad/s, respectively. A strong positive interaction (ΔG' = + 6000 and +130,667 Pa at 1 and 10 rad/s, respectively) was found in mucin dispersion/plain ibuprofen-oleogel mixture. The extent of the negative interaction increased in mucin dispersion/plain ibuprofen-bigel mixture (ΔG' = -59,000 and -79,375 Pa at 1 and 10 rad/s, respectively). After 6 h, ibuprofen release from hydrogel, oleogel, and bigel was 59.5 ± 2.2, 80.6 ± 3.9, and 94.6 ± 3.2%, respectively. Results showed that the rheological and bioadhesive properties and in vitro drug release were influenced by the type of gel formulations.

Entities:  

Keywords:  Hydrogel; bigel; bioadhesion; oleogel; periodontitis; rheology

Mesh:

Substances:

Year:  2018        PMID: 29669437     DOI: 10.1080/03639045.2018.1464021

Source DB:  PubMed          Journal:  Drug Dev Ind Pharm        ISSN: 0363-9045            Impact factor:   3.225


  6 in total

Review 1.  Current status and future of delivery systems for prevention and treatment of infections in the oral cavity.

Authors:  Sevda Şenel; Ayben Işılay Özdoğan; Gülçin Akca
Journal:  Drug Deliv Transl Res       Date:  2021-03-26       Impact factor: 4.617

2.  Analysis of Stability, Rheological and Structural Properties of Oleogels Obtained from Peanut Oil Structured with Yellow Beeswax.

Authors:  Anna Zbikowska; Sylwia Onacik-Gür; Małgorzata Kowalska; Michał Sowiński; Iwona Szymańska; Katarzyna Żbikowska; Katarzyna Marciniak-Łukasiak; Wojciech Werpachowski
Journal:  Gels       Date:  2022-07-18

Review 3.  Polymeric Gels and Their Application in the Treatment of Psoriasis Vulgaris: A Review.

Authors:  Agnieszka Kulawik-Pióro; Małgorzata Miastkowska
Journal:  Int J Mol Sci       Date:  2021-05-12       Impact factor: 5.923

4.  The Effect of Cross-linking Efficiency of Drug-Loaded Novel Freeze Gelated Chitosan Templates for Periodontal Tissue Regeneration.

Authors:  Syed Saad B Qasim; Liebert Parreiras Nogueria; Amr S Fawzy; Umer Daood
Journal:  AAPS PharmSciTech       Date:  2020-06-16       Impact factor: 3.246

5.  Enzyme Responsive Vaginal Microbicide Gels Containing Maraviroc and Tenofovir Microspheres Designed for Acid Phosphatase-Triggered Release for Pre-Exposure Prophylaxis of HIV-1: A Comparative Analysis of a Bigel and Thermosensitive Gel.

Authors:  Sabdat Ozichu Ekama; Margaret O Ilomuanya; Chukwuemeka Paul Azubuike; James Babatunde Ayorinde; Oliver Chukwujekwu Ezechi; Cecilia Ihuoma Igwilo; Babatunde Lawal Salako
Journal:  Gels       Date:  2021-12-24

6.  Characterization of Chlorhexidine-Impregnated Cellulose-Based Hydrogel Films Intended for the Treatment of Periodontitis.

Authors:  Ola Tarawneh; Imad Hamadneh; Rawan Huwaitat; Ameen Rasheed Al-Assi; Abdulla El Madani
Journal:  Biomed Res Int       Date:  2021-09-15       Impact factor: 3.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.